Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth

Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth

Abstract Despite intense research efforts, glioblastoma remains an incurable brain tumor with a dismal median survival time of 15 months. Thus, identifying new therapeutic targets is an urgent need. Here, we show that the lysine methyltransferase SETD8 is overexpressed in 50% of high-grade gliomas....

Full description

Bibliographic Details
Main Authors: Rosa Della Monica, Michela Buonaiuto, Mariella Cuomo, Cristina Pagano, Federica Trio, Davide Costabile, Giulia de Riso, Francesca Sveva Cicala, Maddalena Raia, Raduan Ahmed Franca, Marialaura Del Basso De Caro, Domenico Sorrentino, Giovanna Navarra, Laura Coppola, Lorella Tripodi, Lucio Pastore, Juergen Hench, Stephan Frank, Claudio Schonauer, Giuseppe Catapano, Maurizio Bifulco, Lorenzo Chiariotti, Roberta Visconti
Format: Article
Language:English
Published: Nature Publishing Group 2023-09-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06167-3

Internet

https://doi.org/10.1038/s41419-023-06167-3

Similar Items